24 May 2013
Keywords: cost-effectiveness, copd, combination, therapies, inhaled, steroids, long-acting
Article | 07 June 2004
A combination of inhaled steroids and a long-acting beta 2 agonist is a cost-effective way to preserve lung function in patients ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 June 2004
23 May 2013
© 2013 thepharmaletter.com